Structural Study of Cell Wall Mannan of a Candida Albicans (serotype A) Strain
Overview
Biology
Chemistry
Affiliations
The structure of the mannan of Candida albicans NIH A-207 strain (serotype A) was investigated by adopting mild acetolysis followed by enzymolysis with an Arthrobacter GJM-1 exo-alpha-mannosidase. The resultant oligosaccharides, from pentaose to octaose (where manp = D-mannopyranose), were identified as manp beta (1----2)manp alpha (1----2)manp alpha (1----2)manp alpha (1----2)manp, manp beta (1----2)manp beta (1----2)manp alpha (1----2)manp alpha (1----2)- manp alpha (1----2)manp, manp beta (1----2)manp beta (1----2)manp beta (1----2)manp alpha (1----2)manp alpha (1----2)manp alpha (1----2)manp and manp beta (1----2)manp beta (1----2)manp beta (1----2)manp beta (1----2)manp alpha (1----2)manp alpha (1----2)manp alpha (1----2)manp, respectively. Analyses of alpha-linked oligosaccharides obtained by acetolysis under conventional conditions gave the same oligosaccharides, from biose to heptaose, as those obtained from the mannans of C. albicans NIH B-792 (serotype B) and J-1012 (serotype A, formerly serotype C).
Role of the Candida albicans MNN1 gene family in cell wall structure and virulence.
Bates S, Hall R, Cheetham J, Netea M, MacCallum D, Brown A BMC Res Notes. 2013; 6:294.
PMID: 23886038 PMC: 3750861. DOI: 10.1186/1756-0500-6-294.
Immunochemistry of pathogenic yeast, Candida species, focusing on mannan.
Shibata N, Kobayashi H, Suzuki S Proc Jpn Acad Ser B Phys Biol Sci. 2012; 88(6):250-65.
PMID: 22728440 PMC: 3410142. DOI: 10.2183/pjab.88.250.
Jawhara S, Mogensen E, Maggiotto F, Fradin C, Sarazin A, Dubuquoy L J Biol Chem. 2012; 287(14):11313-24.
PMID: 22291009 PMC: 3322808. DOI: 10.1074/jbc.M111.329300.
Cell wall mannan and cell surface hydrophobicity in Candida albicans serotype A and B strains.
Masuoka J, Hazen K Infect Immun. 2004; 72(11):6230-6.
PMID: 15501748 PMC: 523023. DOI: 10.1128/IAI.72.11.6230-6236.2004.
Masuoka J Clin Microbiol Rev. 2004; 17(2):281-310.
PMID: 15084502 PMC: 387410. DOI: 10.1128/CMR.17.2.281-310.2004.